Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases.

Singhania A, Graham CM, Gabryšová L, Moreira-Teixeira L, Stavropoulos E, Pitt JM, Chakravarty P, Warnatsch A, Branchett WJ, Conejero L, Lin JW, Davidson S, Wilson MS, Bancroft G, Langhorne J, Frickel E, Sesay AK, Priestnall SL, Herbert E, Ioannou M, Wang Q, Humphreys IR, Dodd J, Openshaw PJM, Mayer-Barber KD, Jankovic D, Sher A, Lloyd CM, Baldwin N, Chaussabel D, Papayannopoulos V, Wack A, Banchereau JF, Pascual VM, O'Garra A.

Nat Commun. 2019 Jun 28;10(1):2887. doi: 10.1038/s41467-019-10601-6.

2.

Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.

Sánchez-Ramón S, Conejero L, Netea MG, Sancho D, Palomares Ó, Subiza JL.

Front Immunol. 2018 Dec 17;9:2936. doi: 10.3389/fimmu.2018.02936. eCollection 2018. Review.

3.

Von Hippel-Lindau Protein Is Required for Optimal Alveolar Macrophage Terminal Differentiation, Self-Renewal, and Function.

Izquierdo HM, Brandi P, Gómez MJ, Conde-Garrosa R, Priego E, Enamorado M, Martínez-Cano S, Sánchez I, Conejero L, Jimenez-Carretero D, Martín-Puig S, Guilliams M, Sancho D.

Cell Rep. 2018 Aug 14;24(7):1738-1746. doi: 10.1016/j.celrep.2018.07.034.

4.

Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways.

Cirauqui C, Benito-Villalvilla C, Sánchez-Ramón S, Sirvent S, Diez-Rivero CM, Conejero L, Brandi P, Hernández-Cillero L, Ochoa JL, Pérez-Villamil B, Sancho D, Subiza JL, Palomares O.

Eur J Immunol. 2018 Jan;48(1):180-193. doi: 10.1002/eji.201747024. Epub 2017 Sep 14.

5.

Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production.

Conejero L, Khouili SC, Martínez-Cano S, Izquierdo HM, Brandi P, Sancho D.

JCI Insight. 2017 May 18;2(10). pii: 90420. doi: 10.1172/jci.insight.90420. eCollection 2017 May 18.

6.

A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.

Wagley S, Vanaporn M, Rinchai D, Conejero L, Lertmemongkolchai G, Bancroft GJ, Titball RW.

Microb Pathog. 2017 Jun;107:175-180. doi: 10.1016/j.micpath.2017.03.015. Epub 2017 Mar 18.

7.

Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease.

Champion OL, Gourlay LJ, Scott AE, Lassaux P, Conejero L, Perletti L, Hemsley C, Prior J, Bancroft G, Bolognesi M, Titball RW.

Vaccine. 2016 Mar 29;34(14):1665-71. doi: 10.1016/j.vaccine.2016.02.038. Epub 2016 Feb 23.

8.

The Blood Transcriptome of Experimental Melioidosis Reflects Disease Severity and Shows Considerable Similarity with the Human Disease.

Conejero L, Potempa K, Graham CM, Spink N, Blankley S, Salguero FJ, Pankla-Sranujit R, Khaenam P, Banchereau JF, Pascual V, Chaussabel D, Lertmemongkolchai G, O'Garra A, Bancroft GJ.

J Immunol. 2015 Oct 1;195(7):3248-3261. doi: 10.4049/jimmunol.1500641. Epub 2015 Aug 26.

9.

The condition-dependent transcriptional landscape of Burkholderia pseudomallei.

Ooi WF, Ong C, Nandi T, Kreisberg JF, Chua HH, Sun G, Chen Y, Mueller C, Conejero L, Eshaghi M, Ang RM, Liu J, Sobral BW, Korbsrisate S, Gan YH, Titball RW, Bancroft GJ, Valade E, Tan P.

PLoS Genet. 2013;9(9):e1003795. doi: 10.1371/journal.pgen.1003795. Epub 2013 Sep 12.

10.

Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.

Müller CM, Conejero L, Spink N, Wand ME, Bancroft GJ, Titball RW.

Infect Immun. 2012 Sep;80(9):3247-55. doi: 10.1128/IAI.00178-12. Epub 2012 Jul 9.

11.

Development of vaccines against burkholderia pseudomallei.

Patel N, Conejero L, De Reynal M, Easton A, Bancroft GJ, Titball RW.

Front Microbiol. 2011 Sep 27;2:198. doi: 10.3389/fmicb.2011.00198. eCollection 2011.

12.

Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis.

Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, Felgner PL, Titball RW, Salguero FJ, Bancroft GJ.

Am J Pathol. 2011 Jul;179(1):270-80. doi: 10.1016/j.ajpath.2011.03.031. Epub 2011 May 5.

13.

Assessment of airway distribution of transnasal solutions in mice by PET/CT imaging.

Soto-Montenegro ML, Conejero L, Vaquero JJ, Baeza ML, Zubeldia JM, Desco M.

Mol Imaging Biol. 2009 Jul-Aug;11(4):263-8. doi: 10.1007/s11307-009-0199-y. Epub 2009 Apr 2.

PMID:
19340489
14.

Automatic quantification of histological studies in allergic asthma.

Abella M, Zubeldia JM, Conejero L, Malpica N, Vaquero JJ, Desco M.

Cytometry A. 2009 Mar;75(3):271-7. doi: 10.1002/cyto.a.20648.

15.

Pollen-induced airway inflammation, hyper-responsiveness and apoptosis in a murine model of allergy.

Conejero L, Higaki Y, Baeza ML, Fernández M, Varela-Nieto I, Zubeldia JM.

Clin Exp Allergy. 2007 Mar;37(3):331-8.

PMID:
17359383
16.

Anisakis simplex allergy: a murine model of anaphylaxis induced by parasitic proteins displays a mixed Th1/Th2 pattern.

Baeza ML, Conejero L, Higaki Y, Martín E, Pérez C, Infante S, Rubio M, Zubeldia JM.

Clin Exp Immunol. 2005 Dec;142(3):433-40.

17.

Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL.

de la Concha EG, Fernandez-Arquero M, Lopez-Nava G, Martin E, Allcock RJ, Conejero L, Paredes JG, Diaz-Rubio M.

Gastroenterology. 2000 Dec;119(6):1491-5.

PMID:
11113070
18.

Presence of a protective allele for achalasia on the central region of the major histocompatibility complex.

de la Concha EG, Fernandez-Arquero M, Conejero L, Lazaro F, Mendoza JL, Sevilla MC, Diaz-Rubio M, Ruiz de Leon A.

Tissue Antigens. 2000 Aug;56(2):149-53.

PMID:
11019915
19.

Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis.

Martínez A, Fernández-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, de la Concha EG.

Arthritis Rheum. 2000 Jun;43(6):1366-70.

20.

Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster.

Allcock RJ, de la Concha EG, Fernandez-Arquero M, Vigil P, Conejero L, Arroyo R, Price P.

Hum Immunol. 1999 Dec;60(12):1266-73.

PMID:
10626741
21.

Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis.

Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L, Figueredo MA, de la Concha EG.

Neurology. 1999 Oct 12;53(6):1361-3.

PMID:
10522904
22.

HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID).

De La Concha EG, Fernandez-Arquero M, Martinez A, Vidal F, Vigil P, Conejero L, Garcia-Rodriguez MC, Fontan G.

Clin Exp Immunol. 1999 Jun;116(3):516-20.

23.

Pancolitis and genetic markers in the Spanish population.

Fernández-Arquero M, López-Nava G, García Paredes J, Martínez A, De la Concha EG, Figueredo MA, Conejero L, Vigil P, Díaz Rubio M.

Rev Esp Enferm Dig. 1999 Apr;91(4):269-76. English, Spanish.

PMID:
10348926
24.

Contribution of HLA class II genes to susceptibility in achalasia.

De la Concha EG, Fernandez-Arquero M, Mendoza JL, Conejero L, Figueredo MA, Perez de la Serna J, Diaz-Rubio M, Ruiz de Leon A.

Tissue Antigens. 1998 Oct;52(4):381-4.

PMID:
9820602

Supplemental Content

Loading ...
Support Center